Jeff Tyber Joins TYBR Health Board to Enhance Surgical Recovery Innovations TYBR Health is excited to announce the appointment of Jeff Tyber to its Board of Directors, aiming to improve post-surgical recovery solutions through innovation.

Jeff Tyber Joins TYBR Health Board to Enhance Surgical Recovery Innovations #United_States #Houston #TYBR_Health #B3_GEL #Jeff_Tyber

TYBR Health Launches B3 GEL™ System for Enhanced Post-Surgical Healing in the U.S. TYBR Health has unveiled the B3 GEL™ System, a revolutionary solution to improve post-surgical soft tissue healing. This marks a significant advance in regenerative medicine.

TYBR Health Launches B3 GEL™ System for Enhanced Post-Surgical Healing in the U.S. #United_States #System #Lubbock #TYBR_Health #B3_GEL

TYBR Health Begins Clinical Trial of Innovative B3 GEL™ in Australia for Tendon Surgery TYBR Health has initiated its clinical trial for the B3 GEL™, focusing on improving post-surgical outcomes in tendon surgeries. This study signifies a major step towards enhancing patient recovery.

TYBR Health Begins Clinical Trial of Innovative B3 GEL™ in Australia for Tendon Surgery #Australia #Gold_Coast #Clinical_Trial #TYBR_Health #B3_GEL™

TYBR Health Achieves FDA Clearance for Innovative B3 GEL™ System in Surgical Recovery TYBR Health has received FDA 510(k) clearance for its B3 GEL™, a bioresorbable gel designed to protect healing tissues and support surgical recovery, promising enhanced patient outcomes.

TYBR Health Achieves FDA Clearance for Innovative B3 GEL™ System in Surgical Recovery #United_States #Houston #FDA_510(k) #TYBR_Health #B3_GEL™